Sweden · Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 28.90 billion. The enterprise value is 26.76 billion.
| Market Cap | 28.90B |
| Enterprise Value | 26.76B |
Important Dates
The last earnings date was Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
BioArctic AB has 88.72 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 74.32M |
| Shares Outstanding | 88.72M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 32.20% |
| Owned by Institutions (%) | 43.68% |
| Float | 54.40M |
Valuation Ratios
The trailing PE ratio is 28.28.
| PE Ratio | 28.28 |
| Forward PE | n/a |
| PS Ratio | 14.46 |
| PB Ratio | 14.69 |
| P/TBV Ratio | 14.69 |
| P/FCF Ratio | 20.34 |
| P/OCF Ratio | 20.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.34, with an EV/FCF ratio of 18.83.
| EV / Earnings | 26.17 |
| EV / Sales | 13.39 |
| EV / EBITDA | 19.34 |
| EV / EBIT | 19.56 |
| EV / FCF | 18.83 |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.78 |
| Quick Ratio | 4.76 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.03 |
| Interest Coverage | 675.34 |
Financial Efficiency
Return on equity (ROE) is 71.44% and return on invested capital (ROIC) is 57.77%.
| Return on Equity (ROE) | 71.44% |
| Return on Assets (ROA) | 46.39% |
| Return on Invested Capital (ROIC) | 57.77% |
| Return on Capital Employed (ROCE) | 66.60% |
| Weighted Average Cost of Capital (WACC) | -0.02% |
| Revenue Per Employee | 15.50M |
| Profits Per Employee | 7.92M |
| Employee Count | 129 |
| Asset Turnover | 1.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioArctic AB has paid 233.26 million in taxes.
| Income Tax | 233.26M |
| Effective Tax Rate | 18.58% |
Stock Price Statistics
The stock price has increased by +69.19% in the last 52 weeks. The beta is -0.78, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.78 |
| 52-Week Price Change | +69.19% |
| 50-Day Moving Average | 317.45 |
| 200-Day Moving Average | 296.05 |
| Relative Strength Index (RSI) | 54.90 |
| Average Volume (20 Days) | 234,845 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 2.00 billion and earned 1.02 billion in profits. Earnings per share was 11.52.
| Revenue | 2.00B |
| Gross Profit | 1.94B |
| Operating Income | 1.37B |
| Pretax Income | 1.26B |
| Net Income | 1.02B |
| EBITDA | n/a |
| EBIT | 1.37B |
| Earnings Per Share (EPS) | 11.52 |
Balance Sheet
The company has 2.19 billion in cash and 44.07 million in debt, with a net cash position of 2.15 billion or 24.19 per share.
| Cash & Cash Equivalents | 2.19B |
| Total Debt | 44.07M |
| Net Cash | 2.15B |
| Net Cash Per Share | 24.19 |
| Equity (Book Value) | 1.97B |
| Book Value Per Share | 22.19 |
| Working Capital | 1.97B |
Cash Flow
In the last 12 months, operating cash flow was 1.43 billion and capital expenditures -10.24 million, giving a free cash flow of 1.42 billion.
| Operating Cash Flow | 1.43B |
| Capital Expenditures | -10.24M |
| Depreciation & Amortization | 15.21M |
| Net Borrowing | 890,000 |
| Free Cash Flow | 1.42B |
| FCF Per Share | 16.01 |
Margins
Gross margin is 97.04%, with operating and profit margins of 68.44% and 51.14%.
| Gross Margin | 97.04% |
| Operating Margin | 68.44% |
| Pretax Margin | 62.81% |
| Profit Margin | 51.14% |
| EBITDA Margin | n/a |
| EBIT Margin | 68.44% |
| FCF Margin | 71.07% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.61%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | 0.38% |
| Earnings Yield | 3.54% |
| FCF Yield | 4.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioArctic AB has an Altman Z-Score of 24.72 and a Piotroski F-Score of 6.
| Altman Z-Score | 24.72 |
| Piotroski F-Score | 6 |